Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience Publishes Study With New Positive Data From Vps34 Program

April 30 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * PUBLISHES SCIENTIFIC STUDY WITH NEW POSITIVE DATA FROM
VPS34
PROGRAM
    * RESEARCH RESULTS SHOW THAT SB02024 ACTIVATES IMMUNE SYSTEM
IN
TUMORS IN MALIGNANT MELANOMA AND COLORECTAL CANCER

Source text for Eikon:  ID:nWkrc1vpzs 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Sprint Bioscience AB

See all news